Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > MarkLogic > The Opportunity of Real World Data
 

The Opportunity of Real World Data

White Paper Published By: MarkLogic
MarkLogic
Published:  May 07, 2018
Type:  White Paper
Length:  15 pages

Itís your golden opportunity: Rapidly integrate and harmonize data silos. Enhance drug discovery. Achieve faster time to insight. Get to market faster ó all with less cost than you think.

Explore how Life Sciences organizations can accelerate Real World Evidence (RWE) in a comprehensive and cost efficient manner. Download this white paper to learn about challenges, solutions and most importantly ó how to equip your organization for success. It covers:

  • Executive Summary
  • Real World Evidence: A Critical Complement to RCT's
    • Payers and Providers
    • Drug and Medical Device Manufacturers
    • Patients
  • The Challenges of Real World Data
    • Disparate Data Silos and Multi-Structured Content
    • Data Governance and Security Issues
    • Slow Search and Limited Data Analysis
  • Real World Data Platform Requirements
    • Rapid Data Integration and Harmonization
    • Data Governance, Privacy and Quality Assurance
    • Faster Time to Insight
  • MarkLogicís Database Platform Advances Real World Evidence
  • Customer Use Case
    • A Metadata Catalog for a Fortune 50 Company



Tags : 
data, integration, drug, device, manufacture, science